NEW YORK / RankWire.AI / – p style=”text-align: justify;”U.S. stocks saw modest gains on Wednesday, buoyed by a sharp decline in long-term Treasury yields. The S&P 500 climbed by 16.22 points, or 0.21%, to close at 7,707.98, ending a streak of three consecutive declines. Meanwhile, the Dow Jones Industrial Average advanced by 119.65 points, or 0.22%, finishing at 53,463.05. The Nasdaq Composite increased by 41.38 points, or 0.16%, closing at 26,331.09. The fall in government bond yields helped major indexes recover after several sessions of downward pressure driven by rising borrowing costs.
p style=”text-align: justify;”Bond prices increased following the U.S. Treasury Department’s announcement of expanded liquidity support through larger buybacks of longer-term government debt. Beginning September 9, the maximum purchase amount will be raised from $2 billion to at least $4 billion per operation. This adjustment applies to nominal coupon securities within the 10-to-20-year and 20-to-30-year maturity brackets. The heightened purchase volume will be maintained through November 4. The department explained that strong demand for high-quality offers was a key factor in deciding to increase liquidity operations in these sectors.
p style=”text-align: justify;”Treasury yields responded by falling, reversing some of the recent upward trend in long-term borrowing costs. The 10-year Treasury yield decreased to approximately 4.65%, while the 30-year yield dipped to about 5.20%. Notably, the 30-year yield had reached 5.337% on Tuesday, its highest point since 2007. As bond yields move inversely to prices, increased demand for government debt contributed to the decline in yields. This easing of pressure helped mitigate some of the recent selloff experienced by longer-term government bonds.
h3 style=”text-align: justify;”>Healthcare sector boosts market sentiment
p style=”text-align: justify;”The healthcare sector played a supportive role in Wednesday’s market, with several pharmaceutical stocks posting significant gains. Moderna shares surged 177%, while Merck rose 12.6% after both companies announced positive results from a Phase 3 melanoma trial. The INTerpath-001 study evaluated personalized mRNA therapy intismeran autogene combined with Keytruda following surgical removal of high-risk melanoma. The trial met its primary endpoint of recurrence-free survival, as well as a secondary endpoint measuring survival without distant cancer spread.
p style=”text-align: justify;”This healthcare rally helped offset mixed performances elsewhere, especially within the technology sector. Consumer stocks also contributed to the positive tone after several major corporations released quarterly earnings during the session. Estée Lauder gained more than 16% following its earnings report, adding to the upward momentum among consumer-focused companies. Target and Lowe’s also saw gains after reporting their latest financial results. Smaller companies outperformed larger caps, with the Russell 2000 increasing roughly 0.5%, reflecting a broader market recovery.
h3 style=”text-align: justify;”>Indexes break a three-day losing streak
p style=”text-align: justify;”Wednesday’s rally marked the end of three consecutive days of declines for the Nasdaq, S&P 500, and Dow. The rebound followed earlier weakness caused by rising long-term yields. Despite Wednesday’s gains, the major indexes remain lower for the week overall, with the S&P 500 about 1% below the level from the previous Friday. The Dow has declined approximately 0.5%, while the Nasdaq is down roughly 1.5% for the week so far.
p style=”text-align: justify;”Looking at the broader picture for 2026, the markets remain in positive territory despite this week’s dip and recent bond market pressures. The S&P 500 has gained roughly 12.6% since January 1, while the Dow has increased about 11.2%. The Nasdaq continues to lead with a year-to-date rise of approximately 13.3%. Wednesday’s session provided a modest recovery for Wall Street, driven by lower Treasury yields and gains in the healthcare sector, lifting all three major U.S. stock indexes.